These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33408779)

  • 21. YAP and endothelin-1 signaling: an emerging alliance in cancer.
    Tocci P; Blandino G; Bagnato A
    J Exp Clin Cancer Res; 2021 Jan; 40(1):27. PubMed ID: 33422090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IKBKE Is Required during KRAS-Induced Pancreatic Tumorigenesis.
    Rajurkar M; Dang K; Fernandez-Barrena MG; Liu X; Fernandez-Zapico ME; Lewis BC; Mao J
    Cancer Res; 2017 Jan; 77(2):320-329. PubMed ID: 28069799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.
    Zhao X; Wang X; Fang L; Lan C; Zheng X; Wang Y; Zhang Y; Han X; Liu S; Cheng K; Zhao Y; Shi J; Guo J; Hao J; Ren H; Nie G
    Cancer Lett; 2017 Aug; 402():61-70. PubMed ID: 28576749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Hippo signaling pathway in liver regeneration and tumorigenesis.
    Hong L; Cai Y; Jiang M; Zhou D; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival.
    Rozengurt E; Sinnett-Smith J; Eibl G
    Signal Transduct Target Ther; 2018; 3():11. PubMed ID: 29682330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis.
    Morvaridi S; Dhall D; Greene MI; Pandol SJ; Wang Q
    Sci Rep; 2015 Nov; 5():16759. PubMed ID: 26567630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability.
    Qi Q; Li DY; Luo HR; Guan KL; Ye K
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7255-60. PubMed ID: 26039999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma.
    Drexler R; Küchler M; Wagner KC; Reese T; Feyerabend B; Kleine M; Oldhafer KJ
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):373-391. PubMed ID: 33098447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma.
    Tu B; Yao J; Ferri-Borgogno S; Zhao J; Chen S; Wang Q; Yan L; Zhou X; Zhu C; Bang S; Chang Q; Bristow CA; Kang Y; Zheng H; Wang H; Fleming JB; Kim M; Heffernan TP; Draetta GF; Pan D; Maitra A; Yao W; Gupta S; Ying H
    JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31557131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.
    Wang J; Martin JF
    J Dent Res; 2017 Oct; 96(11):1229-1237. PubMed ID: 28700256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.
    Ram Makena M; Gatla H; Verlekar D; Sukhavasi S; K Pandey M; C Pramanik K
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F; Li C; Zhang X; Peng W; Wen T
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic significance of YAP, TAZ, TEAD4 and p73 in human laryngeal cancer.
    Tsinias G; Nikou S; Mastronikolis N; Bravou V; Papadaki H
    Histol Histopathol; 2020 Sep; 35(9):983-995. PubMed ID: 32378727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas.
    Murakami S; Nemazanyy I; White SM; Chen H; Nguyen CDK; Graham GT; Saur D; Pende M; Yi C
    Dev Cell; 2019 Oct; 51(1):113-128.e9. PubMed ID: 31447265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of DCLK1 down-regulates PD-L1 expression through Hippo pathway in human pancreatic cancer.
    Yan R; Li J; Zhou Y; Yao L; Sun R; Xu Y; Ge Y; An G
    Life Sci; 2020 Jan; 241():117150. PubMed ID: 31837335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fbxw7 Deletion Accelerates Kras
    Zhang Q; Zhang Y; Parsels JD; Lohse I; Lawrence TS; Pasca di Magliano M; Sun Y; Morgan MA
    Neoplasia; 2016 Nov; 18(11):666-673. PubMed ID: 27764699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brahma regulates the Hippo pathway activity through forming complex with Yki-Sd and regulating the transcription of Crumbs.
    Zhu Y; Li D; Wang Y; Pei C; Liu S; Zhang L; Yuan Z; Zhang P
    Cell Signal; 2015 Mar; 27(3):606-13. PubMed ID: 25496831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.